Cargando…
Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats
Hyperlipidemia is a major component of metabolic syndrome, and regarded as one of the main risk factors causing metabolic diseases. We have developed a therapeutic drug, akebia saponin D (ASD), and determined its anti-hyperlipidemia activity and the potential mechanism(s) of action by analyzing the...
Autores principales: | Zhou, Peipei, Yang, Xiaolin, Yang, Zhonglin, Huang, Wenzhe, Kou, Junping, Li, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479315/ https://www.ncbi.nlm.nih.gov/pubmed/30939835 http://dx.doi.org/10.3390/molecules24071268 |
Ejemplares similares
-
Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D–phospholipid complex
por: Shen, Jinyang, et al.
Publicado: (2016) -
Industrial-Scale Preparation of Akebia Saponin D by a Two-Step Macroporous Resin Column Separation
por: Wu, Yue, et al.
Publicado: (2012) -
Treatment with Akebia Saponin D Ameliorates Aβ(1–42)-Induced Memory Impairment and Neurotoxicity in Rats
por: Chen, Yongde, et al.
Publicado: (2016) -
Two New Pentacyclic Triterpene Saponins from the Leaves of Akebia trifoliata
por: Xu, Qiao-Lin, et al.
Publicado: (2016) -
Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds
por: Li, Meng, et al.
Publicado: (2016)